Flp-In™-Jurkat Cell Line
Product Image
Invitrogen™

Flp-In™-Jurkat Cell Line

Flp-In™ Cell Lines are designed for rapid generation of stable cell lines that express a protein of interest from aRead more
Have Questions?
Catalog NumberQuantity
R762071 mL
Catalog number R76207
Price (EUR)
2.920,00
Each
Add to cart
Quantity:
1 mL
Price (EUR)
2.920,00
Each
Add to cart
Flp-In™ Cell Lines are designed for rapid generation of stable cell lines that express a protein of interest from a Flp-In™ expression vector. These cells contain a single stably integrated FRT site at a transcriptionally active genomic locus. Targeted integration of a Flp-In™ expression vector ensures high-level expression of your gene of interest. There are six Flp-In™ Cell Lines available for the generation of isogenic stable cell lines and a Flp-In™ T-REx™ Cell Line for the generation of tetracycline-regulated stable cell lines. Flp-In™-CV-1, Flp-In™-293, Flp-In™-BHK, Flp-In™-Jurkat, and Flp-In™-3T3 Cell Lines were created by transfecting the parent cell lines with pFRT/lacZeo and selecting for stable Zeocin™- resistant clones. The Flp-In™-CHO Cell Line was created by transfecting CHO cells with pFRT/lacZeo2 and selecting for Zeocin™-resistant clones. The Flp-In™ T-REx™-293 Cell Line contains pFRT/lacZeo and pcDNA™6/TR (from the T-REx™ System) stably integrated. Co-transfection of the Flp-In™ Cell Lines with a Flp-In™ expression vector and the Flp recombinase vector, pOG44, results in targeted integration of the expression vector to the same locus in every cell, ensuring homogeneous levels of gene expression.

Choosing your Flp-In™ Vector/Cell Line Combination
The Flp-In™-CV-1, Flp-In™-293, Flp-In™-CHO, and Flp-In™-Jurkat Cell Lines (Figure 1) work well with Flp-In™ vectors that express a gene from the CMV promoter (pcDNA™5/FRT, pcDNA5/FRT/V5-His-TOPO™, and pSecTag/FRT/V5-His-TOPO™). Flp-In™-BHK and Flp-In™-3T3 cells tend to down regulate the CMV promoter. Therefore, it is recommended that the Flp-In™ vectors containing the EF-1α promoter (pEF5/FRT/V5-DEST™ and pEF5/FRT/V5-D-TOPO™) be used with these cell lines.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Cell LineFlp-In™-Jurkat Cell Line
Quantity1 mL
SpeciesHuman
Product LineFlp-In
Protein TagpSec
Unit SizeEach
Contents & Storage
3 x 106 cells are supplied frozen in 1 ml of 90% complete medium and 10% DMSO. Cells must be stored in liquid nitrogen. Cells are guaranteed stable for 6 months when properly stored.

Frequently asked questions (FAQs)

I have your Flp-In Jurkat cells that I tried to thaw using the protocol suggested in your manual, but got very poor viability. What do you think went wrong?

Flp-In Jurkat cells are a little tricky to handle and are very sensitive to centrifugation. You may try the following protocol to thaw the cells:

- Thaw 1 vial of cells into a T25 flask containing 5-7 mL of fresh medium (without selection). Do not spin down the cells to remove the DMSO at this point, as they are very sensitive to handling (including centrifugation). Typically, there is a lot of debris present upon thaw.
- 24 hours post-thaw, spin down the cells at 900 rpm for 2-3 minutes and resuspend gently into 5 mL of fresh medium. Spinning down the entire volume of cells greatly reduces the amount of debris in the culture.
- At day 5 or 6, it is okay to add the selection. Continue to passage the cells (spinning the cells down) every 2-3 days for a total of 1.5 weeks, each time resuspending back into only 5-7 ml of fresh medium in a T25 flask to build up the cell density. The Jurkat cells are very small and clumpy, and they expand very slowly.
- Attempt to expand the cells into a T75 flask only after about 1.5 weeks.

Is multiple integration of the Flp-In expression construct possible? How do you screen for multiple integrants, and how stable is the Flp-In expression cell line?

In theory, one can get multiple integrations of the Flp-In expression construct—an FRT-specific integration event and a random, second-site integration. However, random integration is a relatively uncommon event. Limiting the amount of DNA in the transfection will reduce the chance of second-site integration. We have transfected 293 cells (lacking the FRT site) with the pcDNA5/FRT vector and have identified one potential second-site integrant after screening over 200 clones. DNA integrations can be detected by Southern blot. A single integrant will display a single band; double: two; triple: three, etc. We have maintained a number of Flp-In expression cell lines for over four months and have not observed any loss of the Flp-In expression construct, whether hygromycin selection was maintained or not.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

What kind of Flp-In T-REx cell lines do you offer?

We offer the Flp-In T-REx system that contains pFRT/lacZeo and pcDNA6/TR stably integrated into HEK 293 cells. This cell line has been functionally tested for its ability to regulate expression.

Citations & References (1)

Citations & References
Abstract
The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.
Authors:Xia ZB, Popovic R, Chen J, Theisler C, Stuart T, Santillan DA, Erfurth F, Diaz MO, Zeleznik-Le NJ,
Journal:Proc Natl Acad Sci U S A
PubMed ID:16169901
MLL, involved in many chromosomal translocations associated with acute myeloid and lymphoid leukemia, has >50 known partner genes with which it is able to form in-frame fusions. Characterizing important downstream target genes of MLL and of MLL fusion proteins may provide rational therapeutic strategies for the treatment of MLL-associated leukemia. ... More